Cartesian Therapeutics (RNAC) Goodwill & Intangibles (2023 - 2025)
Historic Goodwill & Intangibles for Cartesian Therapeutics (RNAC) over the last 3 years, with Q3 2025 value amounting to $198.8 million.
- Cartesian Therapeutics' Goodwill & Intangibles changed 0.0% to $198.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $198.8 million for FY2024, which is 0.0% changed from last year.
- Latest data reveals that Cartesian Therapeutics reported Goodwill & Intangibles of $198.8 million as of Q3 2025, which was down 0.0% from $198.8 million recorded in Q2 2025.
- In the past 5 years, Cartesian Therapeutics' Goodwill & Intangibles registered a high of $198.8 million during Q4 2023, and its lowest value of $198.8 million during Q4 2023.
- Its 3-year average for Goodwill & Intangibles is $198.8 million, with a median of $198.8 million in 2023.
- Data for Cartesian Therapeutics' Goodwill & Intangibles shows a peak YoY increase of 0.0% (in 2024) and a maximum YoY decrease of 0.0% (in 2024) over the last 5 years.
- Cartesian Therapeutics' Goodwill & Intangibles (Quarter) stood at $198.8 million in 2023, then changed by 0.0% to $198.8 million in 2024, then changed by 0.0% to $198.8 million in 2025.
- Its last three reported values are $198.8 million in Q3 2025, $198.8 million for Q2 2025, and $198.8 million during Q1 2025.